The Role of Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer: A Network Meta-Analysis.

Fausto Petrelli, Michele Ghidini, Marina Macchini, Giulia Orsi, Umberto Peretti, Sozzi Andrea, Stefano Cascinu, Michele Reni

Journal: Journal of gastrointestinal cancer 2023;54(4):1376-1379

PMID: 36881248

View on PubMed

Abstract

Address: Oncology Unit, ASST Bergamo Ovest, Treviglio, BG, Italy. [email protected].; Oncology Unit, Fondazione Irccs Ospedale Maggiore Policlinico, Milan, Italy.; Department of Medical Oncology, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute IRCCS, Vita-Salute San Raffaele University, Milan, Italy.; Surgery Unit, ASST Bergamo Ovest, Treviglio, BG, Italy.

DOI: 10.1007/s12029-023-00923-6

Link outs

Free resources

Medical:

https://medlineplus.gov/pancreaticcancer.html

MeSH Terms: Humans, Pancreatic Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Neoadjuvant Therapy, Fluorouracil, Leucovorin